Yurvac RHD RSSAuthorisedThis medicine is authorised for use in the European Unionrabbit haemorrhagic disease virus, capsid protein antigen, recombinantMedicineVeterinaryAuthorised
Page contents OverviewProduct detailsAuthorisation detailsAssessment historyNews on Yurvac RHDApplication under evaluationCVMP opinionEuropean Commission decisionOverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information websiteProduct details Name of medicine Yurvac RHD Active substance Rabbit haemorrhagic disease virus, capsid protein antigen, recombinant International non-proprietary name (INN) or common name rabbit haemorrhagic disease virus, capsid protein antigen, recombinant Pharmacotherapeutic groupImmunologicals for leporidaeOther inactivated vaccinesAuthorisation details EMA product number EMEA/V/C/005992 Assessment historyExpand sectionCollapse sectionChanges since initial authorisation of medicineCVMP post-authorisation summary of positive opinion for Yurvac (VRA-0001)AdoptedReference Number: EMA/CVMP/433078/2024 English (EN) (143.29 KB - PDF)First published: 20/09/2024ViewInitial marketing authorisation documentsCVMP summary of positive opinion for YURVAC RHDAdoptedReference Number: EMA/CVMP/311987/2023 English (EN) (118.27 KB - PDF)First published: 14/07/2023ViewNews on Yurvac RHDMeeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 10-12 September 202413/09/2024Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 11-13 July 202314/07/2023This page was last updated on 11/03/2024Share this page